Pharmaceutical manufacturing depends on repeatable inspection. A tablet with a crack, chip, stain, discoloration or other visible anomaly can signal a problem that deserves attention before product moves further downstream. Human inspection remains valuable, but it is inherently variable and difficult to scale consistently across long runs, multiple products and changing operators. Computer vision offers…
Resilience, Lilly invest $750M in pharma, KwikPen manufacturing
Resilience announced today that it expanded its strategic partnership with Eli Lilly (NYSE:LLY) to increase medicine production in the U.S. The Cincinnati-based CDMO and the pharmaceutical giant first struck a partnership in 2023. Now, with $750 million invested, the companies are expanding Resilience’s advanced pharmaceutical manufacturing operations in Ohio. Now, Resilience’s production in that region…
OEE is not a hammer, nor is every problem a nail
Consider a common scenario: a pharmaceutical manufacturing plant has identified the equipment most critical to the success of its processes and has begun tracking overall equipment effectiveness (OEE) for those assets. Management has set an ambitious OEE metric of 95% for those critical machines, and operators and technicians are collaborating closely to make sure they…
How on-site GMP training drives competitive advantage in pharmaceutical manufacturing
In pharmaceutical manufacturing, regulatory compliance isn’t optional. Good Manufacturing Practice (GMP) standards shape every stage of production, from raw material handling to final product release. Companies that treat on-site GMP training as a strategic investment rather than a compliance checkbox gain measurable advantages in efficiency, audit readiness and market competitiveness. Tailored programs can transform compliance…
Schott Pharma invests $60M to expand vial production in Pennsylvania
Schott Pharma announced that it opened up new production lines for both standard and sterile ready-to-use (RTU) glass vials. The company invested more than $60 million, largely funded by the Biomedical Advanced Research and Development Authority (BARDA), to strengthen the resilience of the U.S. pharmaceutical supply chain. It hopes to ensure reliable domestic production of…
Meeting regulatory and quality standards with advanced water purification in biopharma
Nearly every production stage in biopharmaceutical manufacturing depends on highly purified water systems that must consistently meet strict regulatory standards. Why are water quality standards important in biopharmaceutical manufacturing? Biopharmaceutical facilities generally rely on two primary types of purified water. Purified water (PW) is commonly used in nonsterile pharmaceutical manufacturing and equipment cleaning processes. Water…
Niowave breaks ground on $75M isotope production facility
Niowave announced today that it broke ground on a new $75 million production facility in Lansing, Michigan. The isotope manufacturing plant significantly expands the company’s manufacturing footprint and strengthens the domestic supply of Actinium‑225 (Ac‑225), a critical isotope used in next‑generation targeted cancer therapies. The isotope supports targeted cancer therapies designed to destroy cancer cells…
Shibuya highlights cell processing isolator for regenerative medicine manufacturing
Shibuya Corp. is showcasing its Cell Processing Isolator CPi, an isolator-based system designed to support aseptic cell culture and processing for regenerative medicine and cell therapy manufacturing. The CPi system is intended to provide Grade A/ISO 5 particulate air quality environments within a broader cell processing center. Shibuya says the system helps manufacturers reduce direct…
Amerikooler matches walk-in door type to traffic, temperature and opening size
Amerikooler, a U.S. manufacturer of commercial refrigeration equipment, is highlighting its walk-in door portfolio and the selection criteria that determine which door belongs in which application. Door choice drives three measurable outcomes: energy loss through the opening, throughput for workers and equipment moving through it, and how long the door lasts before the gasket, hinges…
Trelleborg exhibits single-use solutions for biopharma customers at Interphex
NEWS RELEASE: Trelleborg exhibits single-use solutions for biopharma customers at Interphex Plymouth, Minnesota – Trelleborg Medical Solutions will exhibit advanced solutions for biopharmaceutical, pharmaceutical and cell and gene therapy applications at Interphex in New York City, April 21 – 23, 2026, at Booth No. 2159. On display is Trelleborg’s BioPharmaPro portfolio, including solutions for bioprocessing,…









